Crossmark

Incorporation of Novel Vascular Measures into Clinical Management: Recent Insights from the Framingham Heart Study

Crossref DOI link: https://doi.org/10.1007/s11906-019-0919-x

Published Online: 2019-02-21

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cooper, Leroy L.

Mitchell, Gary F.
License Information

Text and Data Mining valid from 2019-02-01
More Information

Article History

First Online: 21 February 2019

Compliance with Ethical Standards

:

: Dr. Mitchell reports grants from National Institutes of Health and from Novartis, is a consultant to Merck and Servier, and is Owner and Employee of Cardiovascular Engineering, Inc. Dr. Cooper declares no conflict of interest relevant to this manuscript.

: This article does not contain any studies with human or animal subjects performed by any of the authors.